Developing Novel Antibiotics Against Yersinia pestis

Award Information
Agency:
Department of Health and Human Services
Branch:
N/A
Amount:
$471,409.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43AI063616-01
Agency Tracking Number:
AI063616
Solicitation Year:
2004
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Small Business Information
NOVOBIOTIC PHARMACEUTICALS, LLC
NOVOBIOTIC PHARMACEUTICALS, LLC, 767C CONCORD AVE, CAMBRIDGE, MA, 02138
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
N/A
Principal Investigator
 LOSEE Ling
 (617) 923-8323
 lling@novobiotic.com
Business Contact
Phone: (617) 923-8323
Research Institution
N/A
Abstract
DESCRIPTION (provided by investigator): The overall goal of this project is to develop therapies against Yersinia pestis, the causative agent of plague and one of the most dangerous potential bioweapons. We recently developed a general method to grow pre

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government